SAN DIEGO--(BUSINESS WIRE)--May. 8, 2012--
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Annual
Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00 a.m. PT/ 12:00
p.m. ET from the Company's corporate headquarters in San Diego.
Following the Annual Meeting, Daniel M. Bradbury, president and chief
executive officer of Amylin Pharmaceuticals, will provide a corporate
The call will be webcast live through the "Investors" section of
Amylin's corporate website and a recording will be made available
following the close of the call. To access the webcast, please log on to www.amylin.com
approximately 15 minutes prior to the call to register, download and
install any necessary audio software. For those without access to the
Internet, the live call may be accessed by phone by calling (888)
989-4344 (U.S./Canada) or (312) 470-7140 (international), participant
passcode number 7994841. A replay of the call will also be available by
phone beginning approximately two hours after the close of the call and
can be accessed at (800) 388-5290 (U.S./Canada) or (203) 369-3692
About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a
biopharmaceutical company dedicated to improving lives of patients
through the discovery, development and commercialization of innovative
medicines. Amylin is committed to delivering novel therapies that
transform the way diabetes and other metabolic disorders are treated.
Amylin is headquartered in San Diego, Calif., and has a commercial
manufacturing facility in Ohio. More information on Amylin
Pharmaceuticals is available at www.amylin.com.
Source: Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc.